Evaluation of Ability to Detect Bowel Gas During Laparoscopic Right Colectomy With Intracorporeal Anastomosis
Crohn's Disease of Large Intestine, Malignant Neoplasm of Colon
About this trial
This is an interventional diagnostic trial for Crohn's Disease of Large Intestine focused on measuring Colon cancer, Crohn's disease, Perf-AlertTM device, Hydrogen gas(H2), gas Methane (CH4)
Eligibility Criteria
Inclusion Criteria:
- Male or female ≥ 18 years of age.
- Documentation of a required elective right laparoscopic hemicolectomy with intracorporeal anastomosis
- Subject signed inform consent
Exclusion Criteria:
- Less than 18 years old
- Pregnant or breastfeeding patients
- Patients undergoing emergency laparotomy for perforated right colon or trauma
- Patients with Intraabdominal abscess, peritonitis, or enteric fistula
- Patients who are on peritoneal dialysis
- Subjects do not speak English
Sites / Locations
- Weill Cornell MedicineRecruiting
Arms of the Study
Arm 1
Arm 2
Other
Other
Cohort 1: Predetermined points measurement
Cohort 2: Continuous monitoring
Cohort 1: Predetermined points measurement: 10 subjects with measurement of bowel gas at 8 predetermined time points during right laparoscopic colectomy as follow: Initiation of surgery/laparoscopy start Insufflation Abdominal exploration Completion of colon mobilization Colon transection At Colotomy At Enterotomy Anastomosis completion End of surgery- after re-insufflation before closure
Cohort 2: Continuous monitoring: 10 subjects with continuous monitoring of bowel gases through the surgery. The level of H2 and CH4 gases will be noted at the 8 predetermined time points during the continuous monitoring as well.